# CORRESP — Lexaria Bioscience Corp.  (LEXX)  (CIK 0001348362)

> <strong>Lexaria Bioscience Corp.  (LEXX)  (CIK 0001348362) → SEC staff</strong> · filed 2025-12-05 · ticker LEXX · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001640334-25-002257
- **Form:** CORRESP
- **Filer:** Lexaria Bioscience Corp.  (LEXX)  (CIK 0001348362)
- **CIK:** 0001348362
- **Ticker:** LEXX
- **Filed:** 2025-12-05
- **SIC industry:** 2834
- **HQ:** Kelowna, A1

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1348362/000164033425002257/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1348362&type=UPLOAD&dateb=&owner=include&count=40

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Lexaria Bioscience Corp.  (LEXX)  (CIK 0001348362) (CIK 0001348362), filed 2025-12-05, accession 0001640334-25-002257. Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/comment-letter/0001640334-25-002257.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*